At Winship Cancer Institute of Emory University, we have a team of specialized myeloma experts dedicated to providing you with the very best treatment and outcomes. As the only National Cancer Institute (NCI)-designated Comprehensive Cancer Center in Georgia, we offer access to some of the highest-quality and most innovative care in the nation.
Despite being uncommon, overall, multiple myeloma is the second-most common type of bone and bone marrow cancer. Hundreds of people with multiple myeloma turn to Winship Cancer Institute of Emory University each year for their cancer care.
In the past decade, our multiple myeloma experts have helped pioneer new drug therapies that have doubled the life expectancy of patients, and they are dedicated to building on that success.
As Georgia’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center, Winship is leading cutting-edge research in multiple myeloma and plasma cell disorders with access to novel clinical trials and advanced treatment methods.
As a patient at Winship, you have access to some of the world's leading myeloma experts and a health care team that provides the highest standard of care, the newest clinical trials available and the most up-to-date approaches to managing myeloma.
At Winship, we commit to providing an accurate diagnosis and delivering the best possible care to all patients in a comprehensive care setting. Here is what sets Winship apart:
The people at Emory, in terms of their knowledge, their dedication, their efforts, and their communication about how to manage that cancer that I had and have was just extraordinary.
